Brooks Laboratories Limited (BROOKS.NS)

INR 131.26

(-0.64%)

Total Debt Summary of Brooks Laboratories Limited

  • Brooks Laboratories Limited's latest annual total debt in 2023 was 56.41 Million INR , down -13.36% from previous year.
  • Brooks Laboratories Limited's latest quarterly total debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
  • Brooks Laboratories Limited reported annual total debt of 65.12 Million INR in 2022, down -74.22% from previous year.
  • Brooks Laboratories Limited reported annual total debt of 252.58 Million INR in 2021, down -19.52% from previous year.
  • Brooks Laboratories Limited reported quarterly total debt of 42.07 Million INR for 2023 Q2, down 0.0% from previous quarter.
  • Brooks Laboratories Limited reported quarterly total debt of 56.41 Million INR for 2023 FY, down -13.36% from previous quarter.

Annual Total Debt Chart of Brooks Laboratories Limited (2023 - 2007)

Historical Annual Total Debt of Brooks Laboratories Limited (2023 - 2007)

Year Total Debt Total Debt Growth
2023 56.41 Million INR -13.36%
2022 65.12 Million INR -74.22%
2021 252.58 Million INR -19.52%
2020 313.84 Million INR 13.56%
2019 276.36 Million INR -11.35%
2018 311.75 Million INR 11.4%
2017 279.84 Million INR 115.59%
2016 129.8 Million INR 127.61%
2015 57.02 Million INR 1012.76%
2014 5.12 Million INR 271.21%
2013 1.38 Million INR -87.33%
2012 10.89 Million INR 0.0%
2011 - INR -100.0%
2010 86.66 Million INR -26.69%
2009 118.2 Million INR -26.41%
2008 160.64 Million INR 30.05%
2007 123.52 Million INR 0.0%

Peer Total Debt Comparison of Brooks Laboratories Limited

Name Total Debt Total Debt Difference
Amrutanjan Health Care Limited 17.28 Million INR -226.442%
Biofil Chemicals and Pharmaceuticals Limited 4.38 Million INR -1185.464%
Caplin Point Laboratories Limited 19.7 Million INR -186.391%
FDC Limited 205.18 Million INR 72.503%
Gufic Biosciences Limited 3.32 Billion INR 98.305%
Hikal Limited 8.17 Billion INR 99.31%
Ind-Swift Laboratories Limited 166.21 Million INR 66.057%
IOL Chemicals and Pharmaceuticals Limited 327.6 Million INR 82.778%
Kilitch Drugs (India) Limited 316.46 Million INR 82.172%
Medico Remedies Limited 80.5 Million INR 29.918%
Nectar Lifesciences Limited 6.35 Billion INR 99.112%
Par Drugs and Chemicals Limited - INR -Infinity%
RPG Life Sciences Limited - INR -Infinity%
Sequent Scientific Limited 4.87 Billion INR 98.843%
Shilpa Medicare Limited 9.37 Billion INR 99.398%
Sigachi Industries Limited 1.43 Billion INR 96.056%
Themis Medicare Limited 957.92 Million INR 94.11%
Unichem Laboratories Limited 2.47 Billion INR 97.721%
Venus Remedies Limited 413.3 Million INR 86.349%
Wanbury Limited 1.16 Billion INR 95.157%
ZIM Laboratories Limited 1.08 Billion INR 94.816%
Lupin Limited 29.21 Billion INR 99.807%
Innova Captab Limited 2.45 Billion INR 97.698%
Ind-Swift Limited 10.13 Billion INR 99.444%
Bajaj HealthCare Limited 3.32 Billion INR 98.305%
Aurobindo Pharma Limited 66.47 Billion INR 99.915%
Solara Active Pharma Sciences Limited 10.11 Billion INR 99.442%
AstraZeneca Pharma India Limited 45.98 Million INR -22.698%
Mangalam Drugs & Organics Limited 984.92 Million INR 94.272%
Morepen Laboratories Limited 289.99 Million INR 80.545%
Laurus Labs Limited 25.77 Billion INR 99.781%
Aarti Drugs Limited 5.64 Billion INR 99.0%
Glenmark Life Sciences Limited 171.48 Million INR 67.099%
Alembic Limited 91.5 Million INR 38.34%
Alembic Pharmaceuticals Limited 5.13 Billion INR 98.901%
Glenmark Pharmaceuticals Limited 12.3 Billion INR 99.542%
Vaishali Pharma Limited 134.91 Million INR 58.183%
Aarti Pharmalabs Limited 2.85 Billion INR 98.022%
Jagsonpal Pharmaceuticals Limited 89.41 Million INR 36.899%
Jubilant Pharmova Limited 36.64 Billion INR 99.846%
Eris Lifesciences Limited 27.81 Billion INR 99.797%
Windlas Biotech Limited 36.41 Million INR -54.955%
Sun Pharmaceutical Industries Limited 32.73 Billion INR 99.828%
Lincoln Pharmaceuticals Limited 10.66 Million INR -428.862%
Orchid Pharma Limited 1.35 Billion INR 95.826%
Albert David Limited 33.24 Million INR -69.722%
Hester Biosciences Limited 2.44 Billion INR 97.691%
Sakar Healthcare Limited 793.51 Million INR 92.89%
Suven Pharmaceuticals Limited 649.96 Million INR 91.32%
Procter & Gamble Health Limited 95.6 Million INR 40.984%
Divi's Laboratories Limited 30 Million INR -88.063%
Mankind Pharma Limited 2.07 Billion INR 97.277%
Neuland Laboratories Limited 953.89 Million INR 94.085%
J. B. Chemicals & Pharmaceuticals Limited 3.77 Billion INR 98.506%
Zydus Lifesciences Limited 8.04 Billion INR 99.298%
Wockhardt Limited 23.56 Billion INR 99.761%
Bal Pharma Limited 1.39 Billion INR 95.96%
Dr. Reddy's Laboratories Limited 20.02 Billion INR 99.718%
Bliss GVS Pharma Limited 998.4 Million INR 94.349%
Alkem Laboratories Limited 14.18 Billion INR 99.602%
Valiant Laboratories Limited 767.08 Million INR 92.645%
Ajanta Pharma Limited 352.8 Million INR 84.008%
Bafna Pharmaceuticals Limited 243.89 Million INR 76.867%
Aarey Drugs & Pharmaceuticals Limited 313.52 Million INR 82.005%
Granules India Limited 13.15 Billion INR 99.571%
Medicamen Biotech Limited 308.17 Million INR 81.692%
Ipca Laboratories Limited 14.38 Billion INR 99.608%
Syncom Formulations (India) Limited 724.86 Million INR 92.217%
Piramal Enterprises Limited 535.85 Billion INR 99.989%
Torrent Pharmaceuticals Limited 40.22 Billion INR 99.86%
NATCO Pharma Limited 3.71 Billion INR 98.48%
Suven Life Sciences Limited 7.09 Million INR -694.97%
Krebs Biochemicals & Industries Limited 1.93 Billion INR 97.083%
Strides Pharma Science Limited 25.16 Billion INR 99.776%
Indoco Remedies Limited 6.71 Billion INR 99.16%
Alpa Laboratories Limited 52.46 Million INR -7.536%
Lasa Supergenerics Limited 220.76 Million INR 74.444%
Sun Pharma Advanced Research Company Limited 611.5 Million INR 90.774%